# FDA Inspection 1166493 - Octapharma Plasma Inc - March 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8cc0bed8-3600-4ef6-95a7-df8deb5605f7
Source feed: FDA_Inspections

> FDA Inspection 1166493 for Octapharma Plasma Inc on March 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166493
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1166493 - 2022-03-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/30c9543b-869e-45e1-b0c8-bc8638d4c00f)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/29edb0c3-acbc-4b07-9ecf-ff558bca8c97

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d